Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Chrysant Steven G.  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 473-482

Adis International

Access to resources Recommend Favorite

Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus

By Kereiakes Dean J.  

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 251-257

Adis International

Access to resources Recommend Favorite

Combination Therapy with Olmesartan Medoxomil and Hydrochlorothiazide: Secondary Analysis of the Proportion of Patients Achieving Recommended Blood Pressure Goals from a Randomized, Double-Blind, Factorial Study

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 241-251

Adis International

Access to resources Recommend Favorite

Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy: Post Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Mourad Jean-Jacques   >  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension: Subgroup Analysis of the BENIFICIARY Study

By Neutel Joel M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 289-303

Adis International

Access to resources Recommend Favorite